Liao JI - Search Results

1

Performance status as a prognostic surrogate in hepatocellular carcinoma: Role of albumin-bilirubin and easy-albumin-bilirubin grade.

Liao JI, Ho SY, Hou MC, Liu PH, Hsu CY, Huo TI. Liao JI, et al. J Chin Med Assoc. 2024 Feb 1;87(2):156-162. doi: 10.1097/JCMA.0000000000001036. Epub 2023 Dec 12. J Chin Med Assoc. 2024. PMID: 38095597

2

A New Tumor Burden Score and Albumin-Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma.

Ho SY, Liu PH, Hsu CY, Huang YH, Liao JI, Su CW, Hou MC, Huo TI. Ho SY, et al. Among authors: liao ji. Cancers (Basel). 2022 Jan 27;14(3):649. doi: 10.3390/cancers14030649. Cancers (Basel). 2022. PMID: 35158917 Free PMC article.

3

Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.

Ho SY, Yuan MH, Liu PH, Hsu CY, Huang YH, Liao JI, Su CW, Wang CL, Hou MC, Huo TI. Ho SY, et al. Among authors: liao ji. Scand J Gastroenterol. 2023 Jan;58(1):61-69. doi: 10.1080/00365521.2022.2098052. Epub 2022 Jul 13. Scand J Gastroenterol. 2023. PMID: 35830511

4

Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.

Ho SY, Liu PH, Hsu CY, Huang YH, Liao JI, Su CW, Hou MC, Huo TI. Ho SY, et al. Among authors: liao ji. Expert Rev Gastroenterol Hepatol. 2022 Sep;16(9):903-911. doi: 10.1080/17474124.2022.2117156. Epub 2022 Sep 1. Expert Rev Gastroenterol Hepatol. 2022. PMID: 35999514

5

Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score.

Ho SY, Liu PH, Hsu CY, Huang YH, Liao JI, Su CW, Hou MC, Huo TI. Ho SY, et al. Among authors: liao ji. Cancers (Basel). 2022 Aug 30;14(17):4207. doi: 10.3390/cancers14174207. Cancers (Basel). 2022. PMID: 36077743 Free PMC article.

6

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade.

Liao JI, Ho SY, Liu PH, Hsu CY, Huang YH, Su CW, Hou MC, Huo TI. Liao JI, et al. Cancers (Basel). 2023 Jan 25;15(3):753. doi: 10.3390/cancers15030753. Cancers (Basel). 2023. PMID: 36765711 Free PMC article.

7

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Ho SY, Liu PH, Hsu CY, Huang YH, Liao JI, Su CW, Hou MC, Huo TI. Ho SY, et al. Among authors: liao ji. Cancers (Basel). 2023 Mar 23;15(7):1925. doi: 10.3390/cancers15071925. Cancers (Basel). 2023. PMID: 37046586 Free PMC article.

8

Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score.

Ho SY, Liu PH, Hsu CY, Huang YH, Lei HJ, Liao JI, Su CW, Hou MC, Huo TI. Ho SY, et al. Among authors: liao ji. Sci Rep. 2023 Aug 24;13(1):13871. doi: 10.1038/s41598-023-41068-7. Sci Rep. 2023. PMID: 37620558 Free PMC article.

9

Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there yet?

Huo TI, Liao JI, Ho SY. Huo TI, et al. Among authors: liao ji. J Hepatol. 2022 Apr;76(4):987-988. doi: 10.1016/j.jhep.2021.11.007. Epub 2021 Nov 13. J Hepatol. 2022. PMID: 34780876 No abstract available.

10

Improving the accuracy of outcome prediction for hepatocellular carcinoma: Asia strategies.

Huo TI, Ho SY, Liao JI. Huo TI, et al. Among authors: liao ji. Liver Int. 2022 Mar;42(3):714-715. doi: 10.1111/liv.15167. Epub 2022 Feb 2. Liver Int. 2022. PMID: 35065002 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters